Johnson & Johnson has opened the J&J Innovation Center in London, one of four regional hubs being established this year. The goal of the Innovation Center is to accelerate early stage science and advance the development of new healthcare solutions.
"The London Innovation Center is part of Johnson & Johnson's broader innovation strategy to advance human health through collaboration with the world's leading scientists and entrepreneurs,” said Paul Stoffels, M.D., J&J chief scientific officer and worldwide chairman, pharmaceuticals.
The Innovation Center will house science and technology experts with expertise in developing new solutions and products. The Center will have local deal-making capabilities to flexibly adapt deal structures to match early-stage opportunities. This will enable scientists, entrepreneurs and emerging companies to deliver innovation via collaboration with experts who can drive partnerships across the pharmaceutical, medical device & diagnostics and consumer healthcare companies of J&J.
Similar facilities are planned in Boston, San Francisco and Shanghai.